entertainment -WSS

entertainment

author：leisure time 2025-09-27 23:00:19 - browse：787

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Can CDC director Mandy Cohen drive consensus in Washington?

WSS

KalVista pill reduced swelling 'attacks' caused by genetic disease

Biogen Alzheimer’s drug launch off to slow start

Grail faces three suits alleging harassment, retaliation

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Biden report: The neurospychology of memory and aging

knowledge

entertainment

entertainment

Activists slam private health insurers over coverage restrictions

KalVista pill reduced swelling 'attacks' caused by genetic disease

After affirmative action ruling, medical educators look to 'holistic review'

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: How biotech is using artificial intelligence

Hollywood unions extend contract negotiations for actors

Biden report: The neurospychology of memory and aging

ChatGPT in medicine: STAT answers readers' burning questions

J&J expands global access to TB drug amid advocacy campaign

focus

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

To avoid data mishandling cases, universities eye AI and other tools

For Medicare Advantage, Democrats want stronger protections around AI

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

J&J expands global access to TB drug amid advocacy campaign

hotspot

knowledge

focus

Wikipedia